This AXL targeting antibody conjugated to MMAE was evaluated in AXL-high mouse models of melanoma and lung cancer and found to produce an inflammatory microenvironment characterised by an influx of T cells with a skew to lymphocytes with a memory-like phenotype (CD137-high) [158]. This evidence concerns the gene TNFRSF9 and lung cancer.